Gilead Sciences CMO Reports Routine RSU Vesting and Tax Withholding
GILEAD SCIENCES, INC.
Subscribe to track GILD
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Form 4 Alert: Gilead Sciences, Inc. ($GILD) Insider: Berger Dietmar (Chief Medical Officer) Type: Tax Withholding (RSU Vesting) Shares Transacted: 263 shares @ $144.81 ($38,085.03) Shares Owned Following: 19,522 shares Significance: Low
Comprehensive Analysis
Transaction Analysis: Gilead Sciences, Inc. ($GILD)
Overview
On September 10, 2026, Dietmar Berger, Chief Medical Officer of Gilead Sciences, Inc., executed transactions related to the vesting of restricted stock units (RSUs):
- Acquisition (Code M): Acquired 533 shares of Common Stock upon the vesting and conversion of an equivalent number of RSUs at $0.00.
- Disposition (Code F): Disposed of 263 shares of Common Stock at $144.81 per share to cover statutory tax withholding obligations resulting from the RSU vesting.
Key Details
- Net Share Change: Net increase of 270 direct shares.
- Ending Direct Holdings: 19,522 shares of Common Stock.
- Remaining Derivative Holdings: 46,395 unvested RSUs.
Significance Assessment
This filing reflects a routine compensation-related event (automatic vesting and mandatory share withholding for tax liability) rather than open-market buying or selling. Therefore, the trading significance is rated as Low.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.